Key result
Baseline LV thrombus on CMR is linked to ~138% higher major cardiovascular events risk.
Why the study?
Factors associated with left ventricular thrombus have mainly been reported after recent myocardial infarction, leaving limited data in chronic ischemic cardiomyopathy.
Cohort (n=790)
No
In patients with chronic ischemic cardiomyopathy, the presence of left ventricular thrombus detected by CMR is independently associated with a more than two-fold increased risk of major adverse cardiovascular events.
Answers are grounded in this paper and cite their sources.
CMR-detected LVT signals higher MACE risk in chronic ischemic cardiomyopathy; hypothesis-generating for anticoagulation trials before practice change.
BACKGROUND: Left ventricular thrombus (LVT) is a significant complication in ischemic cardiomyopathy (ICM). However, factors associated with LVT have mainly been reported in patients with recent myocardial infarction (MI), while data in chronic ICM remain limited. This study aimed to identify factors associated with CMR-detected LVT in patients with chronic ICM (left ventricular ejection fraction [LVEF] < 50% of ischemic etiology, >40 days post-MI), develop a CMR-based risk score, and evaluate the prognostic implications of LVT on major adverse cardiovascular events (MACE). METHODS: This study included 790 patients with ICM who underwent CMR at an academic hospital in Thailand between 2016 and 2023. Factors associated with LVT were identified using logistic regression analyses. A CMR-based risk score was developed and validated, with discriminative performance assessed by the area under the receiver operating characteristic curve (AUC-ROC). MACE, defined as a composite of cardiovascular death, ischemic stroke, transient ischemic attack, systemic embolism, nonfatal MI, or heart failure hospitalization, was also evaluated. Factors associated with MACE were assessed using Cox regression analysis. CONCLUSIONS: In patients with ICM undergoing CMR, apical aneurysm, apical LGE, and LGE extent were independently associated with LVT. The CMR-LVT Score demonstrated acceptable discriminative performance for identifying higher-risk patients who may benefit from more intensive follow-up. LVT was also independently associated with MACE.
No takes yet. Share an insight, caveat, or question.
Aramcharoen et al. (2026) conducted a cohort in Chronic ischemic cardiomyopathy (n=790). Left ventricular thrombus (LVT) detected by CMR vs. Absence of left ventricular thrombus was evaluated on Major adverse cardiovascular events (MACE) (adjusted HR 2.38, 95% CI 1.31-4.30, p=0.004). The presence of left ventricular thrombus on baseline cardiac magnetic resonance was independently associated with an increased risk of major adverse cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: